Market Research Logo

Global Veterinary Vaccines Market 2017-2021

Global Veterinary Vaccines Market 2017-2021

About Veterinary Vaccines

Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens. The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.

Technavio’s analysts forecast the global veterinary vaccines market to grow at a CAGR of 4.81% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global veterinary vaccines market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Veterinary Vaccines Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Elanco
  • Merck
  • Merial
  • Zoetis
Other prominent vendors
  • Advaxis
  • AmpliPhi Biosciences
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva Animal Health
  • Colorado Serum Company
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • ImmuCell
  • Nexvet
  • Nuovo Biologics
  • UBI
  • Valneva
  • Vetoquinol
  • Virbac
Market driver
  • Dependency on livestock products.
  • For a full, detailed list, view our report
Market challenge
  • Manufacturing and storage issues.
  • For a full, detailed list, view our report
Market trend
  • Robust R&D and improved product portfolio.
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Veterinary Vaccines Market 2017-2021

Technavio recognizes the following companies as the key players in the global veterinary vaccines market: Elanco, Merck, Merial, and Zoetis.

Other Prominent Vendors in the market are: Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac.

Commenting on the report, an analyst from Technavio’s team said: “One trend in market is inorganic growth strategies. The animal care market has been witnessing an increase in strategic alliances and acquisitions among vendors. The vendors undertake inorganic growth strategies such as acquisitions and/or partnerships to expand their product portfolio and to improve their penetration in the emerging markets.”

According to the report, one driver in market is advances in technology. The advances in technology have improved the overall pharmacokinetics and dynamics of vaccines. The use of cell line culture in the manufacture of viral vaccinations has increased, which have improved the quality of vaccinations. For instance, GE Healthcare and Valneva have collaborated to produce optimized cell culture for vaccine production. The advances in the purification process of vaccination have improved the product quality and reduced the cost. The development of new ligands for affinity chromatography, like lectin-affinity chromatography for downstream processing of cell culture, helped Sigma-Aldrich derive the influenza A viruses. These advances in technology are adding to the vaccine sales globally. For instance, the launch of various mobile applications such as PocketVet and Pet First Aid, help the owners get reminders regarding vaccines, which increases the awareness and boosts the usage of vaccines.

Further, the report states that one challenges in market is manufacturing and storage issues. Vaccines involve a complex network of processes, ranging from manufacturing to delivery. The cost-intensive manufacturing issues associated with vaccines get quadrupled with strict regulatory laws. The protocol set by the FAO for manufacturing animal vaccines involve stringent processes like Master Seed and Master Stock analysis. These processes are important in producing quality vaccines as they involve the analysis of microbes, which are used in vaccines manufacturing, followed by sterilization and storage processes. All these processes need to fulfill the required regulatory limits to get the desired product with safety and efficacy profiles. The downstream processing of these vaccines contributes to a major cost of production and is very crucial to conserve the purity of the product.

Companies Mentioned

Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, and Virbac.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Key market highlights
  • An overview of major animal diseases
    • Table Overview of major animal diseases
  • Market landscape
    • Market overview
      • Table Global veterinary vaccines market snapshot
      • Table Global veterinary vaccines market 2016-2021 ($ millions)
      • Table Opportunity analysis in global veterinary vaccines market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by technology
    • Table Market segmentation by technology 2016
    • Live attenuated vaccines
      • Table Veterinary live attenuated vaccines: Vendors and indications
      • Table Global veterinary live attenuated vaccines market 2016-2021 ($ millions)
    • Inactivated/Killed vaccines
      • Table Veterinary inactivated vaccines: Vendors and indications
      • Table Global veterinary inactivated vaccines market 2016-2021 ($ millions)
    • Toxoid vaccines
      • Table Examples: Veterinary toxoid vaccines with their indications and vendors
      • Table Global veterinary toxoid vaccines market 2016-2021 ($ millions)
    • DNA vaccines
      • Table Veterinary DNA vaccines
      • Table Global veterinary DNA vaccines market 2016-2021 ($ millions)
    • Recombinant vector vaccines
      • Table Veterinary recombinant vector vaccines
      • Table Global veterinary recombinant vector vaccines market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Global veterinary vaccines market by geography 2016 and 2021
    • Table Global veterinary vaccines market revenue by geography 2016-2021 ($ millions)
    • Veterinary vaccines market in Americas
      • Table Market scenario in Americas
      • Table Veterinary vaccines market in Americas 2016-2021 ($ millions)
    • Veterinary vaccines market in EMEA
      • Table Market scenario in EMEA
      • Table Veterinary vaccines market in EMEA 2016-2021 ($ millions)
    • Veterinary vaccines market in APAC
      • Table Market scenario in APAC
      • Table Veterinary vaccines market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Major requirements for CVB product approval
      • Table Impact of drivers and challenges
      • Table Key drivers and challenges for impact analysis
  • Market trends
    • Table Recent strategic alliances in animal healthcare
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global veterinary vaccines market 2016
      • Table Competitive factors of global veterinary vaccines market
      • Table Market penetration of lifestyle drug manufacturers worldwide 2016
      • Table Strategic success factors of companies in global veterinary vaccine market
      • Table Key news in veterinary vaccines market
  • Key vendor analysis
    • Elanco
      • Table Elanco: Key highlights
      • Table Elanco: Strength assessment
      • Table Elanco: Strategy assessment
      • Table Elanco: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Merial
      • Table Merial: Key highlights
      • Table Merial: Strength assessment
      • Table Merial: Strategy assessment
      • Table Merial: Opportunity assessment
    • Zoetis
      • Table Zoetis: Key highlights
      • Table Zoetis: Strength assessment
      • Table Zoetis: Strategy assessment
      • Table Allergan: Opportunity assessment
    • Other prominent vendors
      • Table Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report